We are experiencing extremely high call volume related to COVID-19 vaccine interest. Please understand that our phone lines must be clear for urgent medical care needs. We are unable to accept phone calls to schedule COVID-19 vaccinations at this time. When this changes, we will update this web site. Please know that our vaccine supply is extremely small. Read all COVID-19 Vaccine Information.
Patient Care Options | Visitor Guidelines | Coronavirus Information | Self-Checker | Get Email Alerts
Enter the last name, specialty or keyword for your search below.
The first cancer immunotherapy was approved in 2011; today, there are more than 70 such drugs in the clinical pipeline. By 2020, the cancer treatment industry is expected to achieve $16.55 billion dollars in revenue. Read our policy brief to learn more about milestones in cancer immunotherapy.
Hear from top scientists on how they recommend expanding and implementing the Blue Ribbon Panel’s road map for cancer research. They’ll discuss a report that will be published by the journal The Lancet Oncology and is co-edited by Elizabeth Jaffee, M.D., deputy director of the Johns Hopkins Kimmel Cancer Center, and Chi Van Dang, M.D., Ph.D., scientific director at Ludwig Cancer Research and professor at The Wistar Institute. Learn what you need to know about investing in research, prevention and treatment of cancer, the second leading cause of death in the U.S. Reserve your attendance now by emailing JHontheRoad@jhmi.edu.
Wednesday, November 1, from 8:30 a.m. to 12:00 p.m.
Capitol Hill Hart Senate Office Building, Room 902
120 Constitution Avenue NE, Washington, D.C. 20002
Paul Rothman, M.D.
Dean of the Medical Faculty
CEO, Johns Hopkins Medicine
David Collingridge, Ph.D.
Editor-in-Chief, The Lancet Oncology
Elizabeth Jaffee, M.D.
Professor of Oncology and Deputy Director, Johns Hopkins Sidney Kimmel Cancer Center
Associate Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy
Chi Van Dang, M.D., Ph.D.
Scientific Director, Ludwig Institute for Cancer Research
Professor, The Wistar Institute
Scott Lippman, M.D.
Professor of Medicine, Senior Associate Dean and Associate Vice Chancellor for Cancer Research and Care, University of California, San Diego
Jeffrey Peppercorn, M.D., M.P.H.
Director, Cancer Survivorship Program, Massachusetts General Hospital
Associate Professor of Medicine at Harvard Medical School
Cliff Hudis, M.D., F.A.C.P.
Chief Executive Officer of the American Society of Clinical Oncology
Douglas Lowry, M.D.
Deputy Director, National Cancer Institute
Sign Up for Fundamentals
Stay up-to-date with the latest research findings from the Institute for Basic Biomedical Sciences.
Language Assistance Available:
© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System. All rights reserved.
